17.07.2013 Views

View Annual Report - Jules Stein Eye Institute

View Annual Report - Jules Stein Eye Institute

View Annual Report - Jules Stein Eye Institute

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

72 Faculty<br />

michael D. Olson, OD, PhD<br />

Associate Research Ophthalmologist<br />

ReseaRch summaRy<br />

Comprehensive Ophthalmology<br />

Dr. Olson’s research activities focus on the visual and<br />

surgical outcomes following cataract surgery. This<br />

includes the surgical correction of refractive errors,<br />

evaluating the safety and efficacy of specialty use<br />

ocular implants, and functional visual outcomes following<br />

ocular trauma cases and complicated cataract<br />

surgery. He is currently investigating three iris implants:<br />

the HumanOptic Artificial Iris, which is a customized,<br />

handmade color match of the patient’s fellow eye;<br />

Morcher GmbH aniridia implants; and the Ophtec<br />

Reconstruction Lens for the treatment of eyes with<br />

congenital aniridia, acquired iris defects, or complete<br />

aniridia. He is also investigating a unique intraocular<br />

lens whose power can be modified after implantation,<br />

correcting the residual refractive error, both spherical<br />

and astigmatic, to improve uncorrected visual acuity.<br />

maria carolina Ortube, mD<br />

Assistant Research Ophthalmologist<br />

Clinical Director of Research Studies,<br />

Retinal Disorders and Ophthalmic Genetics Division<br />

ReseaRch summaRy<br />

Ocular Genetics<br />

Dr. Ortube is a fellowship-trained specialist in pediatric<br />

ophthalmology, strabismus, and pediatric genetic conditions.<br />

She is an investigator in four clinical and translational<br />

research projects related to ocular genetics.<br />

The genetics of inherited eye disorders and Stargardt<br />

protocols provide clinical characterization of affected<br />

individuals and at-risk family members. The Genetics<br />

of Age-Related Maculopathy study focuses on the<br />

genetic and environmental risk factors that contribute<br />

to age-related maculopathy. The protocols use state-ofthe-art<br />

imaging and functional technologies in conjunction<br />

with molecular genetic testing to identify causative<br />

genes and mutations. Dr. Ortube has a special interest<br />

in children born with craniofacial ocular disorders.<br />

She is also investigating a simple, noninvasive, rapid<br />

method for widespread screening of diabetics using the<br />

pupillary light reflex. This study aims to identify those<br />

who may require medical attention and/or therapy for<br />

diabetic retinopathy. Dr. Ortube is a co-investigator in<br />

collaborative research efforts with the University of<br />

Pittsburgh and Neurokinetics, Inc.<br />

Roxana a. Radu, mD<br />

Associate Research Ophthalmologist<br />

ReseaRch summaRy<br />

Retinoids Metabolism in the <strong>Eye</strong><br />

and Underlying Mechanisms of<br />

Macular Degeneration<br />

Dr. Radu’s research focuses on the visual cycle and<br />

underlying biochemical and molecular mechanisms of<br />

macular degeneration. She studies the in vivo association<br />

of the complement negative regulator genes and<br />

age-related macular degeneration (AMD) development.<br />

The mechanism by which dysfunction of complement<br />

factor H (CFH, one of the complement regulatory<br />

genes) causes AMD is not known. To investigate the<br />

relationship between abnormal build-up of vitamin A-<br />

based toxic compounds such as A2E and the complement<br />

system, Dr. Radu will generate a mouse lacking<br />

both genes ABCA4 and CFH. This complex mouse<br />

genetic model will advance understanding of the<br />

relationship between lipofuscin accumulation, complement<br />

activation, and photoreceptor degeneration in<br />

AMD, and it will be a valuable tool for developing new<br />

treatments for this disease.<br />

Kiyo sakagami, PhD<br />

Assistant Research Ophthalmologist<br />

ReseaRch summaRy<br />

Hedgehog Signaling and PTEN/PI3K<br />

Signaling on Retinal Development<br />

Dr. Sakagami’s research aims to understand how<br />

extracellular signals coordinate retinal cell fate and<br />

behavior during development, using genetic strategies<br />

for conditional mutagenesis in the mouse. The more<br />

specific goals of her research are to understand how<br />

hedgehog signaling regulates bHLH genes to determine<br />

cell cycle and cell fate decisions and to investigate<br />

the potential role of PTEN/PI3K signaling on<br />

retinal formation.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!